This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ResMed (RMD) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ResMed (RMD) delivered earnings and revenue surprises of 7.01% and 7.95%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Cresco Labs (CRLBF)
by Zacks Premium Research
Cresco Labs (CRLBF) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Senestech, Inc. (SNES) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Senestech, Inc. (SNES) delivered earnings and revenue surprises of -4.76% and 40.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zevia (ZVIA) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Zevia (ZVIA) delivered earnings and revenue surprises of 19.05% and 7.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of -27.78% and 2.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GrowGeneration (GRWG) Opens 1st Hydroponic Store in Virginia
by Zacks Equity Research
GrowGeneration (GRWG) opens a new store in Virginia and signs two new leases in New Jersey and Missouri, progressing well on its strategy to grow its retail presence across North America.
Ayr Wellness Inc. (AYRWF) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Ayr Wellness Inc. (AYRWF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cresco Labs Inc. (CRLBF) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Cresco Labs Inc. (CRLBF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.